| Item Type | Name |
|
Concept
|
Dose-Response Relationship, Radiation
|
|
Concept
|
Neoplasms, Radiation-Induced
|
|
Concept
|
Radiation Dosage
|
|
Concept
|
Radiation Injuries
|
|
Concept
|
Radiation Injuries, Experimental
|
|
Concept
|
Radiation Protection
|
|
Concept
|
Radiation Tolerance
|
|
Concept
|
Radiation-Protective Agents
|
|
Concept
|
Radiation-Sensitizing Agents
|
|
Concept
|
Radiation, Ionizing
|
|
Concept
|
Tomography, X-Ray Computed
|
|
Concept
|
X-Rays
|
|
Concept
|
Radiation Oncology
|
|
Academic Article
|
Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: the importance of dose-volume effects.
|
|
Academic Article
|
Radiation dose-volume effects in the brain.
|
|
Academic Article
|
A comparison of preplan transrectal ultrasound with preplan-CT in assessing volume and number of seeds needed for real-time ultrasound-based intra-operative planning in prostate (125)I seed implantation.
|
|
Academic Article
|
Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas.
|
|
Academic Article
|
Differential regulation of p53 function by the N-terminal ?Np53 and ?113p53 isoforms in zebrafish embryos.
|
|
Academic Article
|
Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigators.
|
|
Academic Article
|
Epidermal growth factor receptor expression modulates antitumor efficacy of vandetanib or cediranib combined with radiotherapy in human glioblastoma xenografts.
|
|
Academic Article
|
Evaluation of nuclear factor ?B and chemokine receptor CXCR4 co-expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610.
|
|
Academic Article
|
Cediranib enhances control of wild type EGFR and EGFRvIII-expressing gliomas through potentiating temozolomide, but not through radiosensitization: implications for the clinic.
|
|
Academic Article
|
Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy.
|
|
Academic Article
|
A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies.
|
|
Academic Article
|
Costs of early adjuvant radiation therapy after radical prostatectomy: a decision analysis.
|
|
Academic Article
|
In reply to Dr. King (Adjuvant radiotherapy after prostatectomy: does waiting for a detectable prostate-specific antigen level make sense?).
|
|
Academic Article
|
mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer.
|
|
Academic Article
|
Post-prostatectomy image-guided radiation therapy: evaluation of toxicity and inter-fraction variation using online cone-beam CT.
|
|
Academic Article
|
Postprostatectomy radiation therapy: an evidence-based review.
|
|
Academic Article
|
Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions.
|
|
Academic Article
|
The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128.
|
|
Academic Article
|
Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro data.
|
|
Academic Article
|
The impact of brachytherapy on prostate cancer-specific mortality for definitive radiation therapy of high-grade prostate cancer: a population-based analysis.
|
|
Academic Article
|
Quality assurance peer review chart rounds in 2011: a survey of academic institutions in the United States.
|
|
Academic Article
|
Molecular profiling to optimize treatment in non-small cell lung cancer: a review of potential molecular targets for radiation therapy by the translational research program of the radiation therapy oncology group.
|
|
Academic Article
|
Implanted dosimeters identify radiation overdoses during IMRT for prostate cancer.
|
|
Academic Article
|
A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas.
|
|
Academic Article
|
Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical school.
|
|
Academic Article
|
Higher levels of c-Met expression and phosphorylation identify cell lines with increased sensitivity to AMG-458, a novel selective c-Met inhibitor with radiosensitizing effects.
|
|
Academic Article
|
Salvage radiotherapy for prostate cancer: Finding a way forward using radiobiological modeling.
|
|
Academic Article
|
Biomarkers of aging and radiation therapy tailored to the elderly: future of the field.
|
|
Academic Article
|
The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis.
|
|
Academic Article
|
Using qualitative measures to improve quality in radiation oncology.
|
|
Academic Article
|
RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.
|
|
Academic Article
|
Pilot study of meaningful use of electronic health records in radiation oncology.
|
|
Academic Article
|
On the merits and limitations of whole-brain radiation therapy.
|
|
Academic Article
|
Stereotactic body radiation therapy for prostate cancer: is the technology ready to be the standard of care?
|
|
Academic Article
|
NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.
|
|
Academic Article
|
Predictors of radiation oncology resident research productivity.
|
|
Academic Article
|
Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort study.
|
|
Academic Article
|
Nutrient restriction and radiation therapy for cancer treatment: when less is more.
|
|
Academic Article
|
?1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1.
|
|
Academic Article
|
Epidermal growth factor receptor mutation status and rad51 determine the response of glioblastoma to multimodality therapy with cetuximab, temozolomide, and radiation.
|
|
Academic Article
|
ALK inhibitor PF02341066 (crizotinib) increases sensitivity to radiation in non-small cell lung cancer expressing EML4-ALK.
|
|
Academic Article
|
Systematic review of hypofractionated radiation therapy for prostate cancer.
|
|
Academic Article
|
Commissioning and implementation of an implantable dosimeter for radiation therapy.
|
|
Academic Article
|
Impact of a radiation oncology elective on the careers of young physicians: update on a prospective cohort study.
|
|
Academic Article
|
Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis.
|
|
Academic Article
|
Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610.
|
|
Academic Article
|
In reply to Franken and Barendsen.
|
|
Academic Article
|
Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer?
|
|
Academic Article
|
Dosimetric analysis of urinary morbidity following prostate brachytherapy (125I vs. 103Pd) combined with external beam radiation therapy.
|
|
Academic Article
|
Impact of postimplant edema on V(100) and D(90) in prostate brachytherapy: can implant quality be predicted on day 0?
|
|
Academic Article
|
The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapy.
|
|
Academic Article
|
Probability of late rectal morbidity in 125I prostate brachytherapy.
|
|
Academic Article
|
Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
|
|
Academic Article
|
Targeting angiogenic processes by combination low-dose paclitaxel and radiation therapy.
|
|
Academic Article
|
COX-2 inhibitors and cancer therapeutics: potential roles for inhibitors of COX-2 in combination with cytotoxic therapy: reports from a symposium held in conjunction with the Radiation Therapy Oncology Group June 2001 Meeting.
|
|
Academic Article
|
Is it necessary to eliminate the posterior dose margin in prostate brachytherapy to achieve an acceptably low risk of late rectal morbidity?
|
|
Academic Article
|
The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data.
|
|
Academic Article
|
A detailed examination of the difference between planned and treated margins in 125I permanent prostate brachytherapy.
|
|
Academic Article
|
Cyclooxygenase (COX)-2-dependent effects of the inhibitor SC236 when combined with ionizing radiation in mammary tumor cells derived from HER-2/neu mice.
|
|
Academic Article
|
Factors predicting for urinary incontinence after prostate brachytherapy.
|
|
Academic Article
|
Involvement of the Fhit gene in the ionizing radiation-activated ATR/CHK1 pathway.
|
|
Academic Article
|
Novel use of zebrafish as a vertebrate model to screen radiation protectors and sensitizers.
|
|
Academic Article
|
Effect of the tumor vascular-damaging agent, ZD6126, on the radioresponse of U87 glioblastoma.
|
|
Academic Article
|
Salvage of suboptimal prostate seed implantation: Reimplantation of underdosed region of prostate base.
|
|
Academic Article
|
Predicting the future from trials of the past: epidermal growth factor receptor expression and outcome of fractionated radiation therapy trials.
|
|
Academic Article
|
Antisense inhibition of cyclin D1 expression is equivalent to flavopiridol for radiosensitization of zebrafish embryos.
|
|
Academic Article
|
In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish model.
|
|
Academic Article
|
VEGF trap in combination with radiotherapy improves tumor control in u87 glioblastoma.
|
|
Academic Article
|
Strategic plans to promote head and neck cancer translational research within the radiation therapy oncology group: a report from the translational research program.
|
|
Academic Article
|
Inhibition of p73 function by Pifithrin-alpha as revealed by studies in zebrafish embryos.
|
|
Academic Article
|
Differential radiation sensitization of human cervical cancer cell lines by the proteasome inhibitor velcade (bortezomib, PS-341).
|
|
Academic Article
|
Biologically conformal treatment: biomarkers and functional imaging in radiation oncology.
|
|
Academic Article
|
Changes in gene expression predicting local control in cervical cancer: results from Radiation Therapy Oncology Group 0128.
|
|
Academic Article
|
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials.
|
|
Academic Article
|
Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.
|
|
Academic Article
|
Nuclear factor kappaB inhibitors alleviate and the proteasome inhibitor PS-341 exacerbates radiation toxicity in zebrafish embryos.
|
|
Academic Article
|
Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model.
|
|
Academic Article
|
Phase I trial using patupilone (epothilone B) and concurrent radiotherapy for central nervous system malignancies.
|
|
Academic Article
|
The responsibilities of a chief resident in radiation oncology: results of a national survey.
|
|
Academic Article
|
Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary.
|
|
Academic Article
|
Phase I trials involving radiation therapy, quantifying the risks.
|
|
Academic Article
|
Hsp90 inhibition enhances PI-3 kinase inhibition and radiosensitivity in glioblastoma.
|
|
Academic Article
|
Treatment-related complications of radiation therapy after radical prostatectomy: comparative effectiveness of intensity-modulated versus conformal radiation therapy.
|
|
Academic Article
|
A novel radiation-induced p53 mutation is not implicated in radiation resistance via a dominant-negative effect.
|
|
Academic Article
|
Potential for dose escalation in the postprostatectomy setting with intensity-modulated radiation therapy: a dosimetric study using EORTC consensus guidelines for target volume contours.
|
|
Academic Article
|
Radiation therapy and the immune system: learning to live together.
|
|
Academic Article
|
Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial.
|
|
Academic Article
|
Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy.
|
|
Academic Article
|
A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma.
|
|
Academic Article
|
The retinoblastoma tumor suppressor modulates DNA repair and radioresponsiveness.
|
|
Academic Article
|
Adjuvant radiation for node-positive disease after prostatectomy: more good news, but who will listen?
|
|
Academic Article
|
Radiation protection of the gastrointestinal tract and growth inhibition of prostate cancer xenografts by a single compound.
|
|
Academic Article
|
Minimizing morbidity in radiation oncology: a special issue from Future Oncology.
|
|
Academic Article
|
Toward an improved understanding of the ionizing radiation induced DNA damage/response networks in human malignancies.
|
|
Academic Article
|
Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative analysis of long-term outcomes.
|
|
Academic Article
|
Current clinical trials testing combinations of immunotherapy and radiation.
|
|
Academic Article
|
Radiation therapy after radical prostatectomy for prostate cancer: evaluation of complications and influence of radiation timing on outcomes in a large, population-based cohort.
|
|
Academic Article
|
Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy.
|
|
Academic Article
|
Assessing adverse events of postprostatectomy radiation therapy for prostate cancer: evaluation of outcomes in the Regione Emilia-Romagna, Italy.
|
|
Academic Article
|
Is robotic arm stereotactic body radiation therapy ?virtual high dose ratebrachytherapy? for prostate cancer? An analysis of comparative effectiveness using published data [corrected].
|
|
Academic Article
|
Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126.
|
|
Academic Article
|
Modeled risk of ischemic heart disease following left breast irradiation with deep inspiration breath hold.
|
|
Academic Article
|
What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation.
|
|
Academic Article
|
RO-ILS: Radiation Oncology Incident Learning System: A report from the first year of experience.
|
|
Academic Article
|
Evaluating the quality, clinical relevance, and resident perception of the radiation oncology in-training examination: A national survey.
|
|
Academic Article
|
A single activity with a practice quality improvement project for faculty and a quality improvement project for residents.
|
|
Academic Article
|
Quality and Reporting Accuracy of Phase 1 Drug Radiation Clinical Trials.
|
|
Academic Article
|
Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas.
|
|
Academic Article
|
The Missing Pieces in Reporting of Randomized Controlled Trials of External Beam Radiation Therapy Dose Escalation for Prostate Cancer.
|
|
Academic Article
|
Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk.
|
|
Academic Article
|
Stereotactic Body Radiation Therapy Delivery in?a?Genetically Engineered Mouse Model of?Lung?Cancer.
|
|
Academic Article
|
Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy.
|
|
Grant
|
Microenvironmental Control of the Radiation Response
|
|
Academic Article
|
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial.
|
|
Academic Article
|
Genomic Classifier Augments the Role of Pathological Features in Identifying Optimal Candidates for Adjuvant Radiation Therapy in Patients With Prostate Cancer: Development and Internal Validation of a Multivariable Prognostic Model.
|
|
Academic Article
|
Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities.
|
|
Academic Article
|
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
|
|
Academic Article
|
?1 integrin- and JNK-dependent tumor growth upon hypofractionated radiation.
|
|
Academic Article
|
Comparison of Online 6 Degree-of-Freedom Image Registration of Varian TrueBeam Cone-Beam CT and BrainLab ExacTrac X-Ray for Intracranial Radiosurgery.
|
|
Academic Article
|
Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases.
|
|
Academic Article
|
Common error pathways seen in the RO-ILS data that demonstrate opportunities for improving treatment safety.
|
|
Academic Article
|
Spine Stereotactic Body Radiation Therapy Residual Setup Errors and Intra-Fraction Motion Using the Stereotactic X-Ray Image Guidance Verification System.
|
|
Academic Article
|
Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate Cancer.
|
|
Academic Article
|
PD-1 Modulates Radiation-Induced Cardiac Toxicity through Cytotoxic T Lymphocytes.
|
|
Academic Article
|
Utilizing 10-Year Results From the American Board of Radiology Clinical Examination to Identify Areas for Programmatic Improvement.
|
|
Academic Article
|
The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules.
|
|
Academic Article
|
Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy.
|
|
Academic Article
|
Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology.
|
|
Academic Article
|
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.
|
|
Academic Article
|
Assessing the Training and Research Environment for Genomics, Bioinformatics, and Immunology in Radiation Oncology.
|
|
Academic Article
|
A Pilot Study of Radiation Therapy in Combination With Pembrolizumab in Patients With Metastatic Renal Cell Cancer.
|
|
Concept
|
Radiation Oncologists
|
|
Academic Article
|
Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer.
|
|
Academic Article
|
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial.
|
|
Academic Article
|
A phase IB clinical trial of 15?Gy HDR brachytherapy followed by hypofractionated/SBRT in the management of intermediate-risk prostate cancer.
|
|
Academic Article
|
Provider Engagement in Radiation Oncology Data Science: Workshop Report.
|
|
Academic Article
|
Virtual Connectivity During Quarantine: The Role of Social Media for Radiation Oncology During COVID-19.
|
|
Academic Article
|
How to Respond to a Ransomware Attack? One Radiation Oncology Department's Response to a Cyber-Attack on Their Record and Verify System.
|
|
Academic Article
|
A Pilot Trial Using Telemedicine in Radiation Oncology: The Future of Health Care Is Virtual.
|
|
Academic Article
|
Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials.
|
|
Academic Article
|
Practical Steps to Mitigate Cybersecurity Attacks on Radiation Oncology Practices.
|
|
Academic Article
|
Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities.
|
|
Academic Article
|
Prospective Trial of Functional Lung Avoidance Radiation Therapy for Lung Cancer: Quality of Life Report.
|
|
Academic Article
|
Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
|
|
Academic Article
|
Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer.
|
|
Academic Article
|
Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets.
|
|
Academic Article
|
Radiation Therapy Oncology Group. Research Plan 2002-2006. Translational Research Program.
|
|
Academic Article
|
The impact of edema on planning 125I and 103Pd prostate implants.
|
|
Academic Article
|
E-mail and oncology: a survey of radiation oncology patients and their attitudes to a new generation of health communication.
|
|
Academic Article
|
Determination of the urethral dose in prostate brachytherapy when the urethra cannot be visualized in the postimplant CT scan.
|
|
Academic Article
|
Effects of androgen suppression and radiation on prostate cancer suggest a role for angiogenesis blockade.
|
|
Academic Article
|
Patient-Reported Outcomes: Comparing Functional Avoidance and Standard Thoracic Radiation Therapy in Lung Cancer.
|
|
Academic Article
|
A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate.
|
|
Academic Article
|
The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy.
|
|
Academic Article
|
The impact of postimplant edema on the urethral dose in prostate brachytherapy.
|
|
Academic Article
|
Defining a future role for radiogenic therapy.
|
|
Academic Article
|
Targeting angiogenic processes by combination rofecoxib and ionizing radiation.
|
|
Academic Article
|
The lag time in initiating clinical testing of new drugs in combination with radiation therapy, a significant barrier to progress?
|
|
Academic Article
|
Effect of post-implant edema on the rectal dose in prostate brachytherapy.
|
|
Academic Article
|
Early toxicity predicts long-term survival in high-grade glioma.
|